![](https://d3ilqtpdwi981i.cloudfront.net/gdk4salHKXFhLwbUxySMMNrQZdA=/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/05/4c/04/054c04c7-f8ed-4b8c-a3cc-95ef518bb951/thumbnail_de9ddad5-0ab8-4d32-ae20-3b1decd6cdcb.jpg)
The phenanthrene-derivative 9-phenanthrol is a recently identified inhibitor of the transient receptor potential melastatin (TRPM) 4 channel, a Ca2+-activated non-selective cation channel whose mechanism of action remains to be determined. Subsequent studies performed on other ion channels confirm the specificity of the drug for TRPM4. In addition, 9-phenanthrol modulates a variety of physiological processes through TRPM4 current inhibition and thus exerts beneficial effects in several pathological conditions. 9-Phenanthrol modulates smooth muscle contraction in bladder and cerebral arteries, affects spontaneous activity in neurons and in the heart, and reduces lipopolysaccharide-induced cell death. Among promising potential applications, 9-phenanthrol exerts cardioprotective effects against ischaemia-reperfusion injuries and reduces ischaemic stroke injuries. In addition to reviewing the biophysical effects of 9-phenanthrol, here we present information about its appropriate use in physiological studies and possible clinical applications.
Available at: http://works.bepress.com/christopher-delnegro/62/